Shenzhen New Industries Biomedical (300832) — Capital Reinvestment Ratio
Shenzhen New Industries Biomedical (300832) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥606.21 Million) in capital expenditures (CN¥45.78 Million). See Shenzhen New Industries Biomedical free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shenzhen New Industries Biomedical Capital Reinvestment Ratio (2012–2024)
This chart tracks Shenzhen New Industries Biomedical's Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for Shenzhen New Industries Biomedical (2012–2024)
Year-by-year Capital Reinvestment Ratio for Shenzhen New Industries Biomedical from 2012 to 2024. For live market cap and broader valuation context, see Shenzhen New Industries Biomedical market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | CN¥1.36 Billion | CN¥439.20 Million | ▲ +42.5% |
| 2023 | 0.23x | CN¥1.42 Billion | CN¥322.20 Million | ▼ -45.8% |
| 2022 | 0.42x | CN¥962.39 Million | CN¥403.22 Million | ▼ -5.5% |
| 2021 | 0.44x | CN¥773.22 Million | CN¥342.94 Million | ▲ +70.0% |
| 2020 | 0.26x | CN¥976.65 Million | CN¥254.82 Million | ▼ -33.7% |
| 2019 | 0.39x | CN¥831.73 Million | CN¥327.11 Million | ▼ -3.1% |
| 2018 | 0.41x | CN¥701.97 Million | CN¥284.87 Million | ▲ +20.6% |
| 2017 | 0.34x | CN¥524.73 Million | CN¥176.51 Million | ▲ +192.3% |
| 2016 | 0.12x | CN¥486.81 Million | CN¥56.03 Million | ▼ -70.5% |
| 2015 | 0.39x | CN¥305.93 Million | CN¥119.50 Million | ▼ -23.4% |
| 2014 | 0.51x | CN¥253.47 Million | CN¥129.21 Million | ▼ -50.7% |
| 2013 | 1.03x | CN¥138.33 Million | CN¥142.95 Million | ▲ +368.9% |
| 2012 | 0.22x | CN¥55.80 Million | CN¥12.30 Million | — |